Sign Up Today and Learn More About CTRL-Labs Stock
Invest in or calculate the value of your shares in CTRL-Labs or other pre-IPO companies through EquityZen's platform.
CTRL-Labs Stock
CTRL-Labs dedicates itself to answering the biggest questions in computing, neuroscience, and design so creators can dream.
About CTRL-Labs Stock
Founded
2017
Headquarters
New York, NY, US
Total Funding
39.0M
Industries
Software, Artificial Intelligence, Data and Analytics
CTRL-Labs dedicates itself to answering the biggest questions in computing, neuroscience, and design so creators can dream. Their work to build a transformative brain-machine interface spans research and challenges at the intersection of computational neuroscience, statistics, machine learning, biophysics, hardware, and human-computer interaction.
CTRL-Labs Press Mentions
Stay in the know about the latest news on CTRL-Labs
CTRL-labs scoops up Myo armband tech from North
TechCrunch • Jun 27, 2019
This Neuroscientist Wants You To Control Your Devices Like A Jedi
Forbes • Mar 22, 2019
CTRL-labs’ first dev kit is a gesture-tracking neural controller
TechCrunch • Dec 10, 2018
Thomas Reardon and CTRL-Labs are building an API for the brain
TechCrunch • Nov 01, 2018
CTRL-Labs Management
Leadership team at CTRL-Labs
Lead Scientist
Jeffrey Seely
Director of R&D
Adam Berenzweig
Join now and verify your accreditation status to gain access to:
- CTRL-Labs Current Valuation
- CTRL-Labs Stock Price
- CTRL-Labs Management
- Available deals in CTRL-Labs and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- CTRL-Labs Cap Table and Funding History by Share Class and Liquidity Preferences
- CTRL-Labs Revenue and Financials
- CTRL-Labs Highlights
- CTRL-Labs Business Model
- CTRL-Labs Risk Factors
- CTRL-Labs Research Report from SACRA Research
Trading CTRL-Labs Stock
How to invest in CTRL-Labs stock?
Accredited investors can buy pre-IPO stock in companies like CTRL-Labs through EquityZen funds. These investments are made available by existing CTRL-Labs shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell CTRL-Labs stock?
Shareholders can sell their CTRL-Labs stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."